Form 4: Shattuck Labs Director Receives Stock Option Grant
Insider Transaction Report
Director Daniel G. Baker was granted options to purchase 81,000 shares of Shattuck Labs common stock.
Summary
- Director Daniel G. Baker received a grant of 81,000 stock options on May 29, 2026.
- The options have an exercise price of $5.95 per share.
- The options vest in full on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting of stockholders.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- Potential future dilution of existing shareholders upon the exercise of these options.
Risks
- Market price volatility affecting the value of the granted options.
- Dependence on continued service to the issuer for the vesting of the options.
Future Outlook
The options vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, contingent upon continued service.
Industry Context
StockSavvy.ai notes that equity grants to directors are standard corporate governance practice in the biotechnology sector to ensure leadership remains incentivized toward long-term clinical and commercial milestones.
Comparison to Industry Standards
- The grant of stock options to non-employee directors is consistent with standard compensation practices for small-cap biotechnology firms.
- Vesting schedules tied to annual meetings are common practice to align director tenure with the corporate governance cycle.
Stakeholder Impact
- Shareholders may experience minor dilution if these options are exercised in the future.
Next Steps
- Vesting of options on the earlier of May 29, 2027, or the next annual meeting of stockholders.
Key Dates
| Date | Description |
|---|---|
| 05/29/2026 | Date of the stock option grant transaction. |
| 05/29/2036 | Expiration date of the stock options. |
| 06/02/2026 | Date the Form 4 was signed and filed. |
Keywords
Shattuck Labs, STTK, Form 4, Insider Trading, Stock Options, Director Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.